Akribes Biomedical
↗Vienna, Austria
Akribes Biomedical is an Austrian biotechnology company founded in 2015 that specializes in precision medicine for chronic wounds. The company utilizes a proprietary translational assay platform, 'HealPredictor,' which uses patient-derived wound exudates (liquid biopsies) to identify and match the most effective therapeutic options for individual patients. This approach addresses the high unmet medical need in chronic wound care, where treatment success has historically been difficult to predict.
The company is developing a pipeline of novel therapeutics, including its lead candidate AKR101, and is exploring the use of PARP inhibitors for wound healing. Akribes is a key participant in several major European research consortia, including FORCE REPAIR (3D-printed wound dressings) and INJECTHEAL (4D injectable hydrogels), funded by the Horizon Europe program.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Wound Healing & Precision Medicine
SIZE & FINANCIALS
Employees:1-50
Revenue:<$1M
Founded:2015
Ownership:private
Status:operating
FUNDING
Stage:Grant
Total Raised:$0.3M
Investors:European Union (Horizon Europe), Austrian Research Promotion Agency (FFG)
PIPELINE
Stage:Preclinical
Lead Drug Stage:Phase 2 Ready
Modalities:Small molecule, Companion Diagnostics, Hydrogels, 3D Bioprinting
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:FORCE REPAIR Consortium (3D-printed wound dressings), INJECTHEAL Consortium (4D injectable hydrogels), Vienna BioCenter
COMPETITION
Position:Niche Player
Competitors:Ilya Pharma, QBiotics, SanuWave, Misonix
LEADERSHIP
Key Executives:
Dr. Barbara Wolff-Winiski - CEO & CSO
Dr. Gabriela Cabral - COO & Project Manager
Mag. Lukas Kadawy - CFO (Consultant)
Scientific Founders:Dr. Barbara Wolff-Winiski, Prof. Dr. Anton Stütz
Board Members:Professor Dr. Gustav Ammerer, Professor Dr. Thomas Luger, Professor Dr. Kim Nasmyth
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Akribes Biomedical. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.